Advanced stage hepatoblastoma, including both locally advanced primary tumors as well as
metastatic disease, poses unique clinical challenges. Despite substantial advances in …

Background Hepatoblastoma is a rare disease that nevertheless accounts for the majority of
liver malignancies in children. Due to limited epidemiological data, therapy for …

Simple Summary Malignant rhabdoid tumors of the liver are very rare pediatric liver tumors
with a devastating prognosis. It is currently unclear which histological subtypes of pediatric …

Introduction Inflammation is closely associated with tumor development and patient
prognosis. The objective of this study is to assess the prognostic value of the preoperative …

Background Excellent outcomes of the extreme procedure of liver resection (LR) for
advanced hepatoblastoma (HB) have been achieved in recent reports. However, liver …

Simple Summary Indocyanine green (ICG) is a safe reagent that has been clinically
approved to assist in intraoperative navigations for the resection of hepatocellular …

Background and Objectives: In children, hepatoblastoma preferentially is managed by liver
resection (LR). However, in irresectable cases, liver transplantation (LT) is required. The aim …

Background Hepatoblastoma (HB) is the most common primary liver cancer in children with
emerging evidence that incidence is increasing globally. While overall survival for low risk …

Aim Hepatoblastoma is the most frequent hepatic tumor in children, and its initial
presentation will affect treatment and prognosis. The aim of this study is to evaluate long …

Objective Hepatoblastoma (HB) is the most common primary hepatic malignancy in
childhood. Relapse occurs in more than 50% of high‐risk patients with a high mortality due …